Shabna Roupal Morais

Shabna Roupal Morais

Auto-generated profile, based on publicly available information

Shabna Roupal Morais

Department of Pharmaceutical Chemistry, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
PDF file
SMShabna Roupal Morais
Shabna Roupal Morais
RNR. Ram Narayanan
R. Ram Narayanan
KSK. P. Sushmitha
K. P. Sushmitha
NSN. Suchithra
N. Suchithra
SSShruti Shankar
Shruti Shankar
MSM. Sugumar
M. Sugumar
Over the years, the pursuit for new antioxidant compounds from natural products has mounted, due to health concerns regarding the potential toxic and side effects spawn from synthetic antioxidants. In this study the antioxidant potential and the cytotoxic activity was studied using hydroxyl radical scavenging assay and MTT assay using MCF 7 breast cancer cell lines. The hydroxyl radical scavenging potential of various solvent extracts of A. spicifera showed that hydroxyl radical scavenging capacity was increased with decreasing concentration of sample extracts. In the present investigation, out of the four extracts (hexane, ethyl acetate, chloroform, methanol) of A. spicifera methanol showed potential hydroxyl radical scavenging activity than vitamin E in the range of 94.84-99.81% at the concentration range of 50μg/ml-1000μg/ml where the percentage inhibition increased with decrease in concentration. While scavenging hydroxyl radical, the ability of methanol extract (99.81%) to scavenge the hydroxyl radical was the highest among other extracts and Vitamin E. The methanolic extract of A.spicifera was evaluated for in-vitro anti-proliferative assay against MCF-7 cell line, where the cells were exposed to different concentrations of the extract. It is inferred from the results that the appearance of cytotoxic changes to the extract was in a concentration dependant manner. The results also indicate that the IC50 value of the extract was found to be 47.58μg/ml.

4 May 2025 in Turkish Computational and Theoretical Chemistry
Verified
Journal Article
Open access
PDF file
AKAswin K
Aswin K
SMShabna Roupal Morais
Shabna Roupal Morais
Introduction: Glioblastoma multiforme (GBM) is a highly aggressive brain tumor that remains challenging to treat due to its resistance to conventional therapies. Despite advances in cancer research, GBM patients face low survival rates often surviving only a few months to a year after diagnosis. Nolatrexed shows notable pharmacological effects and promising therapeutic potential. We explore its interactions, pharmacokinetics and toxicity using computational tools Methods: In-silico investigations were conducted to analyse nolatrexed interactions with GBM targets using network pharmacology which identifies potential targets. The target nolatrexed was optimised and geometry was calculated for the Frontier molecular orbitals (FMO) and visualised using the 6-311(+)G(d)(p) basis set in Gauss View 16. Autodock tools 1.5.7 used for molecular docking, and the results were subsequently validated using Discovery Studio 4.5. ADMET analysed through ADMETlab 2.0, druglito and toxicity estimation software tool (T.E.S.T) . Result: In this study, FMO calculation was performed using Gaussian software were HOMO and LUMO ranges from 2.7059 to 7.9185 eV and shows higher energy gap signifies greater stability and lower reactivity The potential molecular targets of nolatrexed were first identifed using the Swiss Target Prediction platform and pathogenic targets of GBM were identifed using the Genecard, DisGeNET, and CTD database. Followed by compound and disease target overlapping, 69 targets were placed in that JUN, HSP90AA1, STAT3, MTOR, HSP90B1, IGF1R, GSK3B, JAK2, MAP2K1, and SIRT1 were the top-ranked target, which was estimated by CytoHubba plug-in. The molecular docking was performed for nolatrexed towards top 3 genes include mTORC1, mTORC2 and MAP2K1 from the PDB:7YRJ, 7TZO, 5HZE target. The binding score of nolatrexed were – 8.04 kcal/mol and – 7.2 kcal/ mol and -7.69 kcal/ mol respectively. Conclusion: Nolatrexed plays significant role in treatment of brain tumour, which helps to reduce GBM severity. Our findings suggest that nolatrexed hold promise as a potential therapy for GBM.

2 February 2022 in International Journal of Life Science and Pharma Research
Verified
Journal Article
Open access
PBPavithra Bharathy
Pavithra Bharathy
SMShabna Roupal Morais
Shabna Roupal Morais
Get contact to Life Science and Pharma Journal

16 July 2022 in International Journal of Life Science and Pharma Research
Verified
Journal Article
Open access
PDF file
PMPreethi Mullaivendan
Preethi Mullaivendan
SMShabnaRoupal Morais
ShabnaRoupal Morais
Vendor evaluation, a part of the cGMP which is used to ensure the procured products from the vendors,are meeting their quality standards. To avoid the procurement of substandard products from vendors, it is necessary to qualify the vendor / supplier which can avoid the adverse effect on the quality standards, regulatory requirements, and safety of the patients. The main objective of this review paper is to provide an overall outline of the vendor evaluation and to avoid quality failure and promote patient safety. This review paper covers the methods and criteria for evaluating of vendors in the pharmaceutical industry. This paper focuses on vendor evaluation by questionnaire to meet current Good Manufacturing Practice (cGMP). This text reviews the practical challenges faced and strategic plans of the pharmaceutical industry to achieve compliance management and the quality standards of products. An overview of the methods and approaches followed by the pharmaceutical industry to meet the regulatory requirements which were proposed by the leading regulatory bodies like the US Food and Drug Administration (USFDA) and European Medicines Agency (EMA) is briefly described. Most of the studies focus on criteria and methods, but rarely on approaches and questionnaires. Study includes the approaches, methods, criteria and questionnaire to achieve the quality and regulatory compliance and also emphasizes the vendor to stay confident on quality and the compliance of their products produced. The key points on the vendor questionnaire were effectively discussed, which remains the most common and effective method of vendor evaluation. This review paper also helps the professionals to arrive at an overall outline about the vendor evaluation aspects and questionnaire. The outcome of the study shows the importance of vendor evaluation, which helps in supply chain management. , , , .

14 July 2026 in Current Drug Discovery Technologies
Verified
Journal Article
Closed access
PDF file
SVSwathi V.
Swathi V.
CRChandru R.
Chandru R.
SMShabna Roupal Morais
Shabna Roupal Morais
LSLatha S.
Latha S.
SMSailendra Kumar Mahanta
Sailendra Kumar Mahanta
SNSisir Nandi
Sisir Nandi
Introduction: Neuropathic pain, a devastating neurological disorder attributed to impairment or malfunctioning of the somatosensory system, affecting 10% of the world population. Current therapy emphasizes symptomatic management, featuring high-order side effects. Phytocompounds as neuroprotective agents are of growing interest, and can be screened using structure-based docking, and can act upon a variety of pathways with fewer adverse effects. Methods: A comprehensive literature survey was conducted covering studies published between 2000 and 2022 using scientific databases including PubMed, Scopus, Web of Science, ScienceDirect, and Google Scholar. The neuroprotective potential of medicinal plants and their bioactive phytochemicals was screened using in silico experiments targeting neuropathy-related molecular targets, followed by the evaluation of in vitro and in vivo activities. Results: The studies showed that phytochemicals have multitarget neuroprotective activities, including antioxidant activity, modulation of neurotransmitter signaling, inhibition of inflammatory mediators, and modulation of neuropathic signaling ion channels. Several phytochemicals demonstrated notable binding affinities in docking studies, including icariin with NMDA receptors (−12.646 kcal/mol), aegeline with MAO-A (−10.06 kcal/mol) and MAO-B (−10.09 kcal/mol), and zerumbone with cannabinoid receptors CB1 (−7.80 kcal/mol) and CB2 (−9.40 kcal/mol). Other compounds, such as chlorogenic acid, myricetin, rutin, and piperine, also exhibited significant interactions with key neuropathic targets involved in neuroinflammation and pain signaling pathways. Discussion: Docking studies identified that icariin, aegeline, and zerumbone are predicted lead molecules because they can interact with targets of interest, including NMDA, MAO, and CB receptors. Conclusion: Phytochemical neuroprotective drugs offer a promising approach to managing neuropathy. Integration of molecular docking approaches with experimental pharmacological studies provides a powerful strategy for identifying bioactive natural compounds with therapeutic potential. These findings support advancing phytochemicals as lead candidates for the development of safer, more effective treatments for neuropathy and neuropathic pain

25 July 2026 in Archives of Breast Cancer
Verified
Journal Article
Open access
PDF file
DEDeepthi Enumula
Deepthi Enumula
VNVanitha Rani Nagasubramanian
Vanitha Rani Nagasubramanian
SAShyam Sunder Anchuri
Shyam Sunder Anchuri
BDBhawna Dev
Bhawna Dev
PBPrathap Reddy Basani
Prathap Reddy Basani
SMShabna Roupal Morais
Shabna Roupal Morais
Background: Breast cancer is prevalent among women globally and is linked to metabolic syndrome (MetS). Adipokines are implicated in tumor development by influencing metabolic and inflammatory processes. This study evaluated serum adiponectin and leptin levels of breast cancer patients with MetS and their association with clinicopathological tumour characteristics. Methods: A case-control study was conducted in 150 females aged 35-70 years. Cases included 75 newly diagnosed breast cancer with MetS and controls were 75 with MeS matched for age and body mass index (BMI). Serum adiponectin and leptin levels were analysed by direct ELISA and the data using multivariate analysis, ANOVA/Kruskal–Wallis tests, and ROC curve analysis as appropriate. Results: The serum adiponectin levels were significantly lower (7.32 ± 2.54 ng/ml vs 8.67 ± 3.78 ng/ml; p =0.011) and leptin levels were significantly higher (2127.79 ± 244.05 pg/ml vs 1568.21 ± 452.06 pg/ml; p < 0.001) in cases than controls. Adiponectin and leptin showed significant variation across BMI and BI-RADS categories in cases. Leptin levels were significantly associated with Modified Bloom-Richardson score and ER/PR receptor status and remained independently associated with breast cancer in multivariate analysis (adjusted OR = 1.005, 95% CI: 1.002–1.009; p = 0.005). ROC analysis demonstrated the superior diagnostic value of leptin (AUC = 0.847; 95% CI: 0.785–0.909; sensitivity 78.7%, specificity 81.3%) over adiponectin. Conclusion: The high adipokine imbalance depicted as low levels of adiponectin and high leptin levels imply their potential as adjunctive biomarkers for identifying the risk of breast cancer in women with MetS.